To explore the effect of MYBBP1A downregulation on the four renal carcinoma cell lines selected (Table S1), we silenced MYBBP1A with a shRNA and achieved approximately 40–50% reduction of the protein (Fig. 1A). The gene discussed is MYBBP1A; the disease is renal carcinoma.